Ling Shen

5.3k total citations
29 papers, 405 citations indexed

About

Ling Shen is a scholar working on Molecular Biology, Infectious Diseases and Computational Theory and Mathematics. According to data from OpenAlex, Ling Shen has authored 29 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Infectious Diseases and 5 papers in Computational Theory and Mathematics. Recurrent topics in Ling Shen's work include Computational Drug Discovery Methods (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Machine Learning in Bioinformatics (3 papers). Ling Shen is often cited by papers focused on Computational Drug Discovery Methods (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Machine Learning in Bioinformatics (3 papers). Ling Shen collaborates with scholars based in China, United States and Malaysia. Ling Shen's co-authors include Liqian Zhou, Lihong Peng, Li Huang, Xiongfei Tian, Fu‐Xing Liu, Maryam M. Asgari, Eric Jorgenson, A. Hunter Shain, William A. Robinson and Boris C. Bastian and has published in prestigious journals such as Blood, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Ling Shen

26 papers receiving 403 citations

Peers

Countries citing papers authored by Ling Shen

Since Specialization

Citations

This map shows the geographic impact of Ling Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Shen more than expected).

Fields of papers citing papers by Ling Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Shen. The network helps show where Ling Shen may publish in the future.

Co-authorship network of co-authors of Ling Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Shen. A scholar is included among the top collaborators of Ling Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Shen. Ling Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Can companies’ participation in ESG ratings improve green innovation efficiency? Evidence from Chinese A-share listed companies 2025 ·Finance research letters ·Ling Shen, Xiaozhong Yang, (unknown)	1
2	Single-molecule light-scattering imaging for in situ counting circular RNA 2025 ·Nano Today ·Hao Wang, Xin Liu, (unknown), (unknown), Ling Shen, Xiaoyu Wang, Fangfang Wang, Zhengping Li	0
3	Effects of nurse-led cognitive-motor dual-task training based on mobile health technology on the older adults with cognitive frailty: A quasi-experimental study 2024 ·Geriatric Nursing ·(unknown), Ying Zhou, (unknown), (unknown), Feng Lin, Ling Shen, (unknown), Zheng Li	1
4	Membrane Associated RNA‐Containing Vesicles Regulate Cortical Astrocytic Microdomain Calcium Transients in Awake Ischemic Stroke Mice 2024 ·Advanced Science ·Zhongqiu Zhou, Ying Bai, Xiaochun Gu, Hui Ren, Xi Wen, Yu Wang, (unknown), Xue Liu, Ling Shen, Xianyuan Xiang, Wenhui Huang, Zhuojuan Luo, Bing Han, Honghong Yao	1
5	Genome-driven discovery of new serrawettin W2 analogues from Serratia fonticola DSM 4576 2023 ·Organic & Biomolecular Chemistry ·(unknown), (unknown), Ling Shen, Tao Han, Qiang He, Aiying Li, Peng Zhang, Xiaofeng Cai	1
6	Application of Building Information Modelling (BIM) Six Dimension (6D) in Green Buildings: A Case Study of Sunshine and Daylight Analysis 2023 ·Jurnal Kejuruteraan ·(unknown), (unknown), (unknown), (unknown), Ling Shen, (unknown)	1
7	Discovery of Potential Therapeutic Drugs for COVID-19 Through Logistic Matrix Factorization With Kernel Diffusion 2022 ·Frontiers in Microbiology ·Xiongfei Tian, Ling Shen, (unknown), Li Huang, (unknown), Liqian Zhou, Lihong Peng	15
8	LPI-EnEDT: an ensemble framework with extra tree and decision tree classifiers for imbalanced lncRNA-protein interaction data classification 2021 ·BioData Mining ·Lihong Peng, (unknown), Ling Shen, (unknown), Liqian Zhou	21
9	VDA-RWLRLS: An anti-SARS-CoV-2 drug prioritizing framework combining an unbalanced bi-random walk and Laplacian regularized least squares 2021 ·Computers in Biology and Medicine ·Ling Shen, Fu‐Xing Liu, Li Huang, (unknown), Liqian Zhou, Lihong Peng	66
10	A novel lncRNA–protein interaction prediction method based on deep forest with cascade forest structure 2021 ·Scientific Reports ·Xiongfei Tian, Ling Shen, Zhenwu Wang, Liqian Zhou, Lihong Peng	23
11	Prioritizing antiviral drugs against SARS-CoV-2 by integrating viral complete genome sequences and drug chemical structures 2021 ·Scientific Reports ·Lihong Peng, Ling Shen, Junlin Xu, Xiongfei Tian, Fuxing Liu, Juanjuan Wang, Geng Tian, Jialiang Yang, Liqian Zhou	30
12	Screening Potential Drugs for COVID-19 Based on Bound Nuclear Norm Regularization 2021 ·Frontiers in Genetics ·Juanjuan Wang, Chang Wang, Ling Shen, Liqian Zhou, Lihong Peng	5
13	Identifying Effective Antiviral Drugs Against SARS-CoV-2 by Drug Repositioning Through Virus-Drug Association Prediction 2020 ·Frontiers in Genetics ·Lihong Peng, Xiongfei Tian, Ling Shen, Ming Kuang, Tianbao Li, Geng Tian, Jialiang Yang, Liqian Zhou	17
14	RNMFMDA: A Microbe-Disease Association Identification Method Based on Reliable Negative Sample Selection and Logistic Matrix Factorization With Neighborhood Regularization 2020 ·Frontiers in Microbiology ·Lihong Peng, Ling Shen, (unknown), Guangyi Liu, Liqian Zhou	23
15	Non-coding RNAs and Autophagy 2019 ·Advances in experimental medicine and biology ·Honghong Yao, Bing Han, Yuan Zhang, Ling Shen, Rongrong Huang	26
16	Targeted Genomic Profiling of Acral Melanoma 2019 ·JNCI Journal of the National Cancer Institute ·Iwei Yeh, Eric Jorgenson, Ling Shen, Mengshu Xu, Jeffrey P. North, A. Hunter Shain, David Reuß, Hong Wu, William A. Robinson, Adam B. Olshen, Andreas von Deimling, Pui–Yan Kwok, Boris C. Bastian, Maryam M. Asgari	116
17	The Development of the Chinese Intermittent Exotropia Questionnaire 2017 ·Optometry and Vision Science ·Hui Zhu, Ling Shen, (unknown), Shu Xu, (unknown), Zhujun Fu, (unknown), Hu Liu	5
18	Novel Inducers of Fetal Globin Identified through High Throughput Screening (HTS) Are Active In Vivo in Anemic Baboons and Transgenic Mice 2015 ·PLoS ONE ·Michael S. Boosalis, José Sangerman, Gary L. White, Roman F. Wolf, Ling Shen, Yan Dai, Emily White, Levi Makala, Yaqin Li, Betty S. Pace, Mehdi Nouraie, Douglas V. Faller, Susan P. Perrine	21
19	Novel therapeutic candidates, identified by molecular modeling, induce γ-globin gene expression in vivo 2011 ·Blood Cells Molecules and Diseases ·Michael S. Boosalis, Serguei A. Castañeda, Marie Trudel, Rodwell Mabaera, Gary L. White, Christopher H. Lowrey, David W. Emery, (unknown), Ling Shen, William A. Wargin, Regine S. Bohacek, Douglas V. Faller, Susan P. Perrine	15
20	A Verification Study of Fan Gong Dike 2001 ·Ling Shen	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact